Adient (NYSE:ADNT) Price Target Raised to $20.00 at UBS Group

Adient (NYSE:ADNT) had its target price increased by investment analysts at UBS Group from $19.00 to $20.00 in a research note issued to investors on Wednesday,Benzinga reports. The brokerage presently has a “neutral” rating on the stock. UBS Group’s price target suggests a potential upside of 7.33% from the stock’s previous close.

Other equities analysts have also issued reports about the stock. JPMorgan Chase & Co. reduced their target price on shares of Adient from $24.00 to $21.00 and set a “neutral” rating on the stock in a research report on Monday. StockNews.com cut Adient from a “buy” rating to a “hold” rating in a research report on Wednesday, January 22nd. Morgan Stanley cut their target price on Adient from $21.00 to $19.00 and set an “underweight” rating on the stock in a research report on Thursday, November 14th. Barclays reduced their price target on Adient from $24.00 to $21.00 and set an “equal weight” rating for the company in a research report on Wednesday, January 22nd. Finally, Bank of America cut Adient from a “buy” rating to a “neutral” rating and dropped their target price for the company from $30.00 to $24.00 in a research report on Thursday, November 21st. One analyst has rated the stock with a sell rating and nine have assigned a hold rating to the company’s stock. According to data from MarketBeat, Adient currently has a consensus rating of “Hold” and an average target price of $21.88.

Adient Price Performance

ADNT traded up $0.68 during trading on Wednesday, reaching $18.63. 357,881 shares of the company traded hands, compared to its average volume of 1,292,513. The company has a market cap of $1.58 billion, a P/E ratio of 80.88, a PEG ratio of 0.28 and a beta of 2.16. The firm has a fifty day simple moving average of $18.03 and a 200 day simple moving average of $20.62. The company has a debt-to-equity ratio of 0.98, a quick ratio of 0.90 and a current ratio of 1.11. Adient has a 12-month low of $16.28 and a 12-month high of $36.04.

Adient (NYSE:ADNT) last issued its quarterly earnings data on Tuesday, January 28th. The company reported $0.27 EPS for the quarter, missing analysts’ consensus estimates of $0.32 by ($0.05). Adient had a return on equity of 6.86% and a net margin of 0.12%. During the same quarter in the previous year, the firm earned $0.31 earnings per share. On average, equities analysts forecast that Adient will post 2.04 EPS for the current year.

Insider Transactions at Adient

In other news, EVP James Conklin sold 11,500 shares of Adient stock in a transaction that occurred on Wednesday, December 4th. The shares were sold at an average price of $20.25, for a total value of $232,875.00. Following the transaction, the executive vice president now owns 51,829 shares of the company’s stock, valued at $1,049,537.25. The trade was a 18.16 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this link. Corporate insiders own 1.30% of the company’s stock.

Institutional Trading of Adient

Several institutional investors and hedge funds have recently bought and sold shares of ADNT. Hotchkis & Wiley Capital Management LLC boosted its position in Adient by 9.3% during the third quarter. Hotchkis & Wiley Capital Management LLC now owns 5,197,090 shares of the company’s stock valued at $117,298,000 after purchasing an additional 442,200 shares during the last quarter. Pacer Advisors Inc. raised its position in shares of Adient by 38,074.9% in the third quarter. Pacer Advisors Inc. now owns 5,144,445 shares of the company’s stock valued at $116,110,000 after purchasing an additional 5,130,969 shares during the period. State Street Corp boosted its stake in Adient by 4.8% during the 3rd quarter. State Street Corp now owns 3,443,471 shares of the company’s stock valued at $77,719,000 after purchasing an additional 158,017 shares during the period. Pzena Investment Management LLC increased its position in Adient by 45.0% during the third quarter. Pzena Investment Management LLC now owns 2,825,491 shares of the company’s stock worth $63,771,000 after acquiring an additional 877,142 shares during the period. Finally, Charles Schwab Investment Management Inc. raised its stake in shares of Adient by 6.1% in the third quarter. Charles Schwab Investment Management Inc. now owns 963,446 shares of the company’s stock valued at $21,745,000 after purchasing an additional 55,387 shares in the last quarter. Institutional investors and hedge funds own 92.44% of the company’s stock.

About Adient

Adient plc engages in the design, development, manufacture, and market of seating systems and components for passenger cars, commercial vehicles, and light trucks. The company's automotive seating solutions include complete seating systems, frames, mechanisms, foams, head restraints, armrests, and trim covers.